FeesSafety
Pluang+

Global advanced carbon materials market forecasted to grow through 2037 driven by EVs, renewables, aerospace, and AI.

Market News
04 Aug 2026
Researchandmarkets.Com
View Source
Bullish
Global advanced carbon materials market forecasted to grow through 2037 driven by EVs, renewables, aerospace, and AI.

A new market report forecasts significant growth in the global advanced carbon materials sector through 2037, driven by rising demand in electric vehicles, renewable energy, aerospace, defense, and AI infrastructure. The report covers 16 material categories including carbon fibers, nanotubes, graphite, graphene, and biochar, highlighting their expanding commercial applications from batteries to thermal management. Emerging trends like hydrogen fuel cells, carbon capture utilization, and biochar integration with carbon credits are expected to reshape the market. Regulatory support and supply chain localization in North America and Europe further bolster long-term demand and innovation in production technologies.

More News

Fortrea and Omico partner to accelerate biomarker-led cancer drug trials in Australia

Fortrea and Omico partner to accelerate biomarker-led cancer drug trials in Australia

Fortrea Holdings and Omico have formed a partnership to enhance precision oncology research in Australia by linking cancer patients to biomarker-matched clinical trials. This collaboration combines Fortrea's oncology trial expertise with Omico's Prec...

Market News
Bullish
53 minutes ago
Fortrea and Omico partner to speed biomarker-based cancer drug trials in Australia

Fortrea and Omico partner to speed biomarker-based cancer drug trials in Australia

Fortrea Holdings Inc and Omico have formed a partnership to accelerate precision oncology research in Australia by connecting cancer patients to biomarker-driven clinical trials. The collaboration combines Fortrea's expertise in oncology clinical tri...

Market News
Bullish
53 minutes ago
Fortrea and Omico partner to speed biomarker-based cancer drug trials in Australia

Fortrea and Omico partner to speed biomarker-based cancer drug trials in Australia

Fortrea Holdings and Omico have formed a partnership to accelerate precision oncology research in Australia by combining Fortrea's clinical trial expertise with Omico's Precision Oncology Screening Platform (PrOSPeCT). This collaboration aims to impr...

Market News
Bullish
53 minutes ago
Fortrea and Omico partner to accelerate biomarker-driven cancer drug trials in Australia

Fortrea and Omico partner to accelerate biomarker-driven cancer drug trials in Australia

Fortrea Holdings Inc and Omico have formed a partnership to enhance precision oncology research in Australia by matching cancer patients with biomarker-driven clinical trials. This collaboration combines Fortrea's expertise in oncology clinical trial...

Market News
Bullish
53 minutes ago
Fortrea and Omico partner to enhance biomarker-driven cancer drug trials in Australia

Fortrea and Omico partner to enhance biomarker-driven cancer drug trials in Australia

Fortrea Holdings and Omico have formed a partnership to accelerate precision oncology research by improving biomarker-based clinical trial planning and patient recruitment in Australia. The collaboration leverages Fortrea's clinical trial expertise a...

Market News
Bullish
53 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App